Purespring to develop gene therapies for the kidney
Interviewee/Contributor
Richard Francis
Organisation
Purespring Therapeutics Ltd
Research Directory
What we need to know about SARS-CoV-2 variants
Interviewee/ContributorPeter CharlishOrganisationMedNousEpigenetics and the quest for personalised CNS drugs
Interviewee/ContributorCarlos BuesaOrganisationOryzon Genomics SATaming food-induced immune disorders
Interviewee/ContributorPoul SørensenOrganisationAllero Therapeutics BVEU medicine approvals with public health impact
Interviewee/ContributorJane MorrisonOrganisationMedNousTechnology Transfer: Partnering with the US National Cancer Institute
Interviewee/ContributorMichael Salgaller, Michele Newton and Michael PollackOrganisationUS National Cancer InstituteBuilding biotech using an oncology network
Interviewee/ContributorJónas EinarssonOrganisationOslo Cancer Cluster, RadforskForbion to create and grow biotech companies
Interviewee/ContributorSander Slootweg and Juliette AudetOrganisationForbionDrug development robust, despite the pandemic
Interviewee/ContributorBruno PagliaraOrganisationMedNousA record year for the financing of ATMPs
Interviewee/ContributorPaige BischoffOrganisationAlliance for Regenerative Medicine